000			01697 a2200469 4500
005			20250513155253.0
264		0	_c19990226
008			199902s 0 0 eng d
022			_a0028-3908
024	7		_a10.1016/s0028-3908(98)00105-1 _2doi
040			_aNLM _beng _cNLM
100	1		_aPopik, P
245	0	0	_aInhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists. _h[electronic resource]
260			_bNeuropharmacology _cAug 1998
300			_a1033-42 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnalgesics, Opioid _xadverse effects
650	0	4	_aAnalysis of Variance
650	0	4	_aAnimals
650	0	4	_aBinding, Competitive
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aExcitatory Amino Acid Antagonists _xpharmacology
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMorphine _xadverse effects
650	0	4	_aNaloxone _xadverse effects
650	0	4	_aNarcotic Antagonists _xadverse effects
650	0	4	_aQuinolones _xpharmacology
650	0	4	_aRats
650	0	4	_aRats, Wistar
650	0	4	_aReceptors, Glycine _xmetabolism
650	0	4	_aReceptors, N-Methyl-D-Aspartate _xantagonists & inhibitors
650	0	4	_aReinforcement, Psychology
650	0	4	_aSubstance Withdrawal Syndrome
700	1		_aMamczarz, J
700	1		_aFraczek, M
700	1		_aWidła, M
700	1		_aHesselink, M
700	1		_aDanysz, W
773	0		_tNeuropharmacology _gvol. 37 _gno. 8 _gp. 1033-42
856	4	0	_uhttps://doi.org/10.1016/s0028-3908(98)00105-1 _zAvailable from publisher's website
999			_c9797710 _d9797710